AUA 2022: Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography is Associated with Improved Oncological Outcome in Men who Underwent Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer

2022 American Urologic Association Annual Meeting results of a study examining the clinical implications of restaging prostate-specific membrane antigen (PSMA)-PET/CT at the time of biochemical recurrence following radical prostatectomy.

Read the full article here

Related Articles